Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 9, 1997

View Archived Issues

Oligonucleotide compound in development for HIV-1 at Sankyo

Octreotide assessed in treatment of restenosis in VERAS study

Glutarimide tachykinin antagonists reported by Pfizer

CCK-A antagonists for the treatment of pancreatitis

New carbapenem derivatives described by Sankyo

Boehringer Ingelheim presents compounds active against mutant HIV-1 RT

Worldwide agreement between Aradigm and SKB for AERx Pain Management System

Myriad discovers gene's role as tumor suppressor

Periodontal tissue monitor kit launched in U.S.

Mylan receives FDA approval for generic verapamil

Celgene studies chirally pure mexiletine for relief of neuropathic pain

Vical licenses gene delivery technology to RPR

New antineoplastic cryptophycin derivatives

Merck's new fibrinogen receptor antagonists

Roussel Uclaf develops estrogenic compounds

Quadrant, Scherer to develop new oral delivery technology

Pamidronate evaluated as potential therapy for bone cancer

Significant research efforts center on new ketolide at Hoechst Marion Roussel

Flocor pivotal trial supported by FDA grant

CFC-222: a promising therapeutic for bacterial infections

Results from phase I trials with ISIS-3521/CGP-64128A reported

Mutual recognition approval obtained for Astra's angiotensin II blocker

Mechanism of action of oxazolidinones elucidated

Sugen expands SU-101 clinical trials

Neuroprotective effects of PNU-101017 in gerbil model

Cell pathway discovery holds potential for new anticancer treatments

Preliminary results from study of MultiKine in head and neck cancer patients

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...